Literature DB >> 15372625

Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors.

Anne-Marie Heegaard1, Zhongjian Xie, Marian Frances Young, Karina Lishmann Nielsen.   

Abstract

Biglycan is a small leucine-rich proteoglycan which is localized in the extracellular matrix of bone and other specialized connective tissues. Both biglycan mRNA and protein are up-regulated by transforming growth factor-beta(1) (TGF-beta(1)) and biglycan appears to influence TGF-beta(1) activity. In this study, we have investigated the mechanism by which TGF-beta(1), TGF-beta(2) and TGF-beta(3) stimulate biglycan mRNA expression in the osteoblastic cell line MG-63. The cells were transfected with a series of deletional human biglycan promoter constructs and a region in the biglycan 5' DNA was found to respond to TGF-beta(1) with increased transcriptional activity in a dose-dependent manner. Also TGF-beta(2) and TGF-beta(3), two structurally highly related TGF-beta isoforms stimulated biglycan transcription. A TGF-beta responsive region was identified within the first 218 bp of the human biglycan promoter upstream from the transcriptional start site, which contained several binding sites for the transcription factor Sp1. Electrophoretic mobility shift assays with nuclear extracts from MG-63 cells showed binding of both Sp1 and Sp3 to a site at -216 to -208. When the biglycan promoter construct was co-transfected with Sp1 and Sp3 expression vectors in Sp1-deficient Drosophila Schneider-2 cells, Sp1 induced the transcriptional activity of biglycan. Addition of Sp3 augmented the effect of Sp1 on biglycan gene expression. Induction of biglycan mRNA expression in response to TGF-beta in MG-63 cells was abrogated by mithramycin, an inhibitor of Sp1 binding to GC-rich DNA sequences. A mutation in the Sp1 site at -216 to -208 within the -218 biglycan promoter construct substantially diminished the transcriptional up-regulation by TGF-beta(1). Taken together this data shows for the first time that TGF-beta(1) stimulation of human biglycan mRNA expression relies on increased transcription of the biglycan gene, and is mediated by members of the Sp1 family of transcription factors. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372625     DOI: 10.1002/jcb.20189

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

Review 1.  Biglycan in the Skeleton.

Authors:  Vardit Kram; Reut Shainer; Priyam Jani; Josephina A N Meester; Bart Loeys; Marian F Young
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

2.  The Influence of TGF-β3, EGF, and BGN on SOX9 and RUNX2 Expression in Human Chondrogenic Progenitor Cells.

Authors:  Jerome Nicolas Janssen; Sarah Batschkus; Stefan Schimmel; Christa Bode; Boris Schminke; Nicolai Miosge
Journal:  J Histochem Cytochem       Date:  2018-11-15       Impact factor: 2.479

3.  Asporin expression is highly regulated in human chondrocytes.

Authors:  Elise Duval; Nicolas Bigot; Magalie Hervieu; Ikuyo Kou; Sylvain Leclercq; Philippe Galéra; Karim Boumediene; Catherine Baugé
Journal:  Mol Med       Date:  2011-04-25       Impact factor: 6.354

4.  Identification and characterization of the human xylosyltransferase I gene promoter region.

Authors:  Benjamin Müller; Christian Prante; Knut Kleesiek; Christian Götting
Journal:  J Biol Chem       Date:  2009-09-17       Impact factor: 5.157

5.  Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model.

Authors:  Dong Wook Kim; Robert L Walker; Paul S Meltzer; Sheue-yann Cheng
Journal:  Carcinogenesis       Date:  2013-05-22       Impact factor: 4.944

Review 6.  Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma.

Authors:  Francesco Dituri; Gianluigi Gigante; Rosanna Scialpi; Serena Mancarella; Isabel Fabregat; Gianluigi Giannelli
Journal:  Cancers (Basel)       Date:  2022-04-09       Impact factor: 6.575

7.  Fibromodulin-deficiency alters temporospatial expression patterns of transforming growth factor-β ligands and receptors during adult mouse skin wound healing.

Authors:  Zhong Zheng; Kevin S Lee; Xinli Zhang; Calvin Nguyen; Chingyun Hsu; Joyce Z Wang; Todd Matthew Rackohn; Dwarak Reddy Enjamuri; Maxwell Murphy; Kang Ting; Chia Soo
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

8.  Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.

Authors:  Frank Jacobsen; Juliane Kraft; Cornelia Schroeder; Claudia Hube-Magg; Martina Kluth; Dagmar S Lang; Ronald Simon; Guido Sauter; Jakob R Izbicki; Till S Clauditz; Andreas M Luebke; Andrea Hinsch; Waldemar Wilczak; Corinna Wittmer; Franziska Büscheck; Doris Höflmayer; Sarah Minner; Maria Christina Tsourlakis; Hartwig Huland; Markus Graefen; Lars Budäus; Imke Thederan; Georg Salomon; Thorsten Schlomm; Nathaniel Melling
Journal:  Neoplasia       Date:  2017-08-19       Impact factor: 5.715

9.  A core matrisome gene signature predicts cancer outcome.

Authors:  Arseniy E Yuzhalin; Tomas Urbonas; Michael A Silva; Ruth J Muschel; Alex N Gordon-Weeks
Journal:  Br J Cancer       Date:  2018-01-23       Impact factor: 7.640

10.  RhoA Ambivalently Controls Prominent Myofibroblast Characteritics by Involving Distinct Signaling Routes.

Authors:  Aline Jatho; Svenja Hartmann; Naim Kittana; Felicitas Mügge; Christina M Wuertz; Malte Tiburcy; Wolfram-Hubertus Zimmermann; Dörthe M Katschinski; Susanne Lutz
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.